It has been another busy week for Australia's top brokers. This has led to the release of a large number of broker notes.
Three broker buy ratings that you might want to know more about are summarised below. Here's why brokers think these ASX shares are in the buy zone:
Allkem Ltd (ASX: AKE)
According to a note out of Morgans, its analysts have retained their add rating and lifted their price target on this lithium miner's shares to $16.72. The broker was pleased with Allkem's fourth quarter update and believes more of the same is coming in FY 2023 thanks to strong lithium prices and production from Naraha and Stage 2 of Olaroz. The Allkem share price is trading at $10.27 on Friday afternoon.
Liontown Resources Limited (ASX: LTR)
A note out of Macquarie reveals that its analysts have retained their outperform rating and $1.85 price target on this lithium developer's shares. This follows the appointment of Lycopodium Limited (ASX: LYL) to complete the engineering, procurement, construction management (EPCM) and commissioning services for the Kathleen Valley Lithium Project. Macquarie notes that this is an important step to ensuring that things remain on schedule. It expects production to commence in 2024. The Liontown share price is fetching $1.21 this afternoon.
Megaport Ltd (ASX: MP1)
Analysts at Goldman Sachs have retained their buy rating and lifted their price target on this elasticity connectivity provider's shares to $9.60. This follows a quarterly update which revealed stronger than expected growth and a maiden EBITDA profit. Goldman believes the latter de-risks funding concerns, which should be supportive of its valuation. Looking ahead, the broker now expects 30%+ revenue each year through to and including FY 2025. The Megaport share price is trading at $8.73 on Friday.
